A5103135411- Hemoglobinopathies and Related Disorders
- Lymphoma Diagnosis and Treatment
- Blood groups and transfusion
- Acute Myeloid Leukemia Research
- Histiocytic Disorders and Treatments
- Acute Lymphoblastic Leukemia research
- Neutropenia and Cancer Infections
- Parvovirus B19 Infection Studies
- Hematological disorders and diagnostics
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Palliative Care and End-of-Life Issues
- Childhood Cancer Survivors' Quality of Life
- Hematopoietic Stem Cell Transplantation
- Viral-associated cancers and disorders
- Eosinophilic Disorders and Syndromes
- Multiple Myeloma Research and Treatments
- Prenatal Screening and Diagnostics
- COVID-19 Clinical Research Studies
- Iron Metabolism and Disorders
- CNS Lymphoma Diagnosis and Treatment
- Autoimmune and Inflammatory Disorders Research
- SARS-CoV-2 and COVID-19 Research
- Venous Thromboembolism Diagnosis and Management
King Saud bin Abdulaziz University for Health Sciences
2017-2024
King Abdullah International Medical Research Center
2017-2024
National Guard Health Affairs
2020-2024
King Abdulaziz Medical City
2016-2024
European Society for Blood and Marrow Transplantation
2024
Saudi Center for Organ Transplantation
2022-2023
Lincoln County Hospital
2021
Creative Research Enterprises (United States)
2017
University of Khartoum
2008
The prognosis of acute myeloid leukemia (AML) remains poor. Among 180 patients, the median age was 53 (14-88) years. overall 2-year disease free survival (DFS) 28.6% (+/- 3.4), 47.7% 6.6%) for ≤ 40, 23.6% 5.8%) 41–60 and 11.7% 4.2%) ≥61 (p< 0.0001). (OS) 45.3% 3.8%), 78.6% 5.5%) ≤40, 43.5% 6.9%) 15.8% 4.8%) Induction outcome best in high dose chemotherapy (HDC) group (p < Only those ≤40 had durable DFS OS. HDC appears to improve older AML patients.
Introduction Hematological parameters are critical in disease diagnosis, management, and monitoring; however, complete blood count (CBC) reference intervals vary across populations. The aim of the current study was to provide ranges hematological parameters/indices healthy adult Saudi population. Methods A multicenter retrospective cross-sectional conducted with a sample employees who were screened pre-employment from January 2015 December 2019, at tertiary care hospitals three regions....
Patients with terminal diseases frequently undergo interventions that are futile and may be detrimental to their quality of life. We conducted a improvement project aimed reduce the utilization acute care services (ACSs) for patients cancer treated palliative intent.
BACKGROUND:Erdheim-Chester disease (ECD) is a clonal characterized by histiocytic infiltration of multiple organ systems. As ECD rare disorder with variable presentations, its diagnosis and management can present significant clinical challenge. The requires several clinical, radiological, histological criteria. Since approximately 75% patients harbor mutation in the proto-oncogene BRAF V600E, inhibition activation inhibitors has significantly improved ECD. Vemurafenib was approved U.S. Food...
Erdheim-Chester disease (ECD) is a rare type of non-Langerhans cell histiocytosis, with only 550 cases reported worldwide. ECD characterized by diffuse histiocytic infiltration multiorgans. The age presentation this typically between 40 and 70 years. Bone the most common symptom, as unique radiological findings long bone sclerosis occur in 96% cases. Furthermore, BRAF V600E mutation detected 60% In manuscript, we are describing case ECD; patient younger than has no pain or any skeletal...
Background: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a prevalent life-threatening disorder, but there lack of clear data on the nature and local burden this disease in Gulf countries. So, study, we aimed to assess iTTP understand its management pattern Arabian region. Methods: In multinational, multicenter, retrospective were collected from patients’ records included countries (Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman). Patients with diagnosis past 36...
To examine the optimal absolute lymphocyte count (ALC) cut-off utilizing receiver operator characteristics (ROC) in addition to graft associated with early ALC recovery.Patients who received T-cell replete peripheral hematopoietic cell transplantation (HCT) for acute leukemia were identified. was established using ROC analysis and subsequently cohort stratified. Time endpoint cox regression modelling computed analyze outcomes.A total of 72 patients met inclusion criteria analyzed. Optimal be...
Aim: to compare between the prevalence of obstetric anal sphincter injury (OASIS) after cutting mediolareral episiotomy by angled, curved or straight scissors in women labour. Methods: The current randomized controlled trial was conducted at Ain Shams University Maternity Hospital. participating were randomly allocated into three arms. Arm (A): had mediolateral cut angled scissors. (c): .Arm (s): Primary outcome occurrence Obstetric Anal Sphincter Injuries (OASIS). Results A total 300...
23 Background: Patients with terminal diseases frequently undergo procedures and interventions that are futile maybe detrimental to the patients’ quality of life. We conducted a improvement project aimed reduce acute care services (ACS) for cancer patients treated palliative intent. Methods: A multidisciplinary team retrospectively reviewed records terminally ill who died during in hospital at our institution, King Abdulaziz Medical City, Riyadh, Saudi Arabia. included all expired between...